Current Students bannner
Home » Info for » Opioid Abuse Toolkit

Opioid Abuse Toolkit

Resources for New Jersey Communities – 2024

Opioid Abuse Toolkit:  Resources for New Jersey Communities – 2024

Supplementary Materials:

  1. Addressing the Opioid Epidemic Presentation
  2. Social Media Outreach Poster
  3. Securing Prescription Medication Presentation
  4. Community in Crisis Realtor Trifold
  5. Opioid Overdose Poster
  6. Naloxone Administration Poster
  7. Naloxone Administration Training Presentation
  8. Transcript for Naloxone Training
  9. Narcotics Anon NJ Meetings
  10. Narcotics Anon of NJ for Family Members
  11. Drug Take-Back Poster
  12. Student Opioid Evaluation
  13. Drug Abuse Awareness Poster for High School
  14. Drug Abuse Horizontal Banner and Drug Abuse Awareness Sticker
  15. PEERx Partner Presentation
  16. Drug Free Parent Presentation
  17. Drug Abuse Awareness Flyer for Parents
  18. PSA Sticker Drug Abuse
  19. Say No Logo
  20. High School Outreach Presentation
  21. Middle School Outreach Presentation
  22. Say No to Opioids Flyer
  23. Substance Use Overview for Middle/High School – Spanish
  24. Student Overview-Vaping and E Cig Slides
  25. Student Overview – Cocaine Abuse Education Slides
  26. Sharing is Not Caring
  27. Taking the Pledge to Prevent Opioid Misuse
  28. Student Overview – Marijuana Education Slides

 

Opioid Abuse Toolkit: Resources for New Jersey Prescribers – 2024

Supplementary Materials:

  1. Primary Care PTSD Screen (PC-PTSD)
  2. CRAFFT 2.0 Questionnaire*
  3. Opioid Risk Tool
  4. Clinical Opiate Withdrawal Scale (COWS)
  5. Naloxone Administration Poster
  6. National Institute on Drug Abuse – Seeking Drug Abuse Treatment: Know What to Ask (Guide for Patients)
  7. The Facts About Buprenorphine for Patients
  8. Opioid Patient Prescriber Agreement (PPA)
  9. CDC Clinical Practice Guideline for Prescribing Opioids for Pain- 2022
  10. Commonly Used Long-Acting Opioids Chart
  11. How to Change Routes of Administration of Opioids
  12. Buprenorphine Dosing

*NOTICE TO CLINIC STAFF AND MEDICAL RECORDS:
The information on this page is protected by special federal confidentiality rules (42 CFR Part 2), which prohibit disclosure of this information unless authorized by specific written consent. A general authorization for release of medical information is NOT sufficient.
© John R. Knight, MD, Boston Children’s Hospital, 2016.
All rights reserved. Reproduced with permission.
For more information, contact ceasar@childrens.harvard.edu